Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
ESMO Open
|
February 1, 2021
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
M Brahmi, T Lesluyes, A Dufresne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
H-T Arkenau, A Italiano, G Mak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2021
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients
M Aldea, L Cerbone, A Bayle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
Y Loriot, A Marabelle, J P Guégan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study
S Mathoulin-Pélissier, C Chevreau, C Bellera, et al.
Oncoimmunology
|
September 14, 2020
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
A Dufresne, T Lesluyes, C Ménétrier-Caux, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
ESMO Open
|
February 1, 2021
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas
M Brahmi, T Lesluyes, A Dufresne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
A Italiano, M Toulmonde, A Cioffi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
H-T Arkenau, A Italiano, G Mak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2021
Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients
M Aldea, L Cerbone, A Bayle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2021
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
Y Loriot, A Marabelle, J P Guégan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 29, 2013
Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study
S Mathoulin-Pélissier, C Chevreau, C Bellera, et al.
Oncoimmunology
|
September 14, 2020
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma
A Dufresne, T Lesluyes, C Ménétrier-Caux, et al.
ESMO Open
|
June 7, 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
A Le Cesne, C Chevreau, C Perrin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 11, 2014
Effect on survival of local ablative treatment of metastases from sarcomas: a study of the French sarcoma group
A T Falk, L Moureau-Zabotto, M Ouali, et al.
Page
of 14